<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(5)</volume><submitter>Tsai CW</submitter><funding>Dr. Power Stem International Group</funding><pubmed_abstract>Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by two aggregates, namely, amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) of hyperphosphorylated tau protein (tau-p), which are released into the blood in a very small amount and cannot be easily detected. An increasing number of recent studies have suggested that S-glutathionylated glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is highly correlated with Aβ in patients with AD and that S-glutathionylated GAPDH plays a role as a proapoptotic factor in AD. We found that S-glutathionylated GAPDH is abundant in the blood of AD patients, which is unusual because S-glutathionylated GAPDH cannot exist in the blood under normal conditions. The aim of this study was to further explore the correlation betw</pubmed_abstract><journal>PloS one</journal><pagination>e0233289</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7259681</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>An investigation of the correlation between the S-glutathionylated GAPDH levels in blood and Alzheimer's disease progression.</pubmed_title><pmcid>PMC7259681</pmcid><pubmed_authors>Tsai CW</pubmed_authors><pubmed_authors>Hsieh CC</pubmed_authors><pubmed_authors>Tsai CF</pubmed_authors><pubmed_authors>Lin CC</pubmed_authors><pubmed_authors>Lin KH</pubmed_authors><pubmed_authors>Chen WJ</pubmed_authors><pubmed_authors>Lin MS</pubmed_authors></additional><is_claimable>false</is_claimable><name>An investigation of the correlation between the S-glutathionylated GAPDH levels in blood and Alzheimer's disease progression.</name><description>Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by two aggregates, namely, amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) of hyperphosphorylated tau protein (tau-p), which are released into the blood in a very small amount and cannot be easily detected. An increasing number of recent studies have suggested that S-glutathionylated glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is highly correlated with Aβ in patients with AD and that S-glutathionylated GAPDH plays a role as a proapoptotic factor in AD. We found that S-glutathionylated GAPDH is abundant in the blood of AD patients, which is unusual because S-glutathionylated GAPDH cannot exist in the blood under normal conditions. The aim of this study was to further explore the correlation betw</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-22T16:46:42.558Z</modification><creation>2020-06-13T07:08:19Z</creation></dates><accession>S-EPMC7259681</accession><cross_references><pubmed>32469899</pubmed><doi>10.1371/journal.pone.0233289</doi></cross_references></HashMap>